CIBC Bancorp USA’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$726K Buy
2,493
+1,096
+78% +$363K ﹤0.01% 1197
2026
Q2
$468K Buy
1,397
+85
+6% +$26.9K ﹤0.01% 1334
2026
Q1
$423K Buy
+1,312
New +$406K ﹤0.01% 1283

Other funds holding PRAX

CIBC Bancorp USA's PRAX Position: Q3 2026 in Review

CIBC Bancorp USA increased its Praxis Precision Medicines (PRAX) stake by 78% in Q3 2026, buying an estimated $363K and bringing the position to 2,493 shares worth $726K. The position accounts for ﹤0.01% of the portfolio, ranked #1197.

CIBC Bancorp USA first reported a position in PRAX in Q1 2026 and has held it in 3 quarters since. 338 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • CIBC Bancorp USA held 2,493 shares of Praxis Precision Medicines worth $726K as of Q3 2026.
  • CIBC Bancorp USA bought 1,096 Praxis Precision Medicines shares in Q3 2026, an estimated $363K.
  • Praxis Precision Medicines made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1197 holding.
  • CIBC Bancorp USA first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 3 quarters since.
  • 338 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.